Related by context. All words. (Click for frequent words.) 76 Gastric Cancer 75 Rotavirus Vaccine 75 Chronic Hepatitis B 74 Renal Cell Carcinoma 74 Virus Infection 74 Combination Treatment 74 Prolongs Survival 73 Hepatitis B Virus 73 Malignant Melanoma 73 Chronic Hepatitis C 72 Hepatocellular Carcinoma 72 Pulmonary Arterial Hypertension 72 Progressive Multifocal Leukoencephalopathy 72 Myelodysplastic Syndromes 72 Monoclonal Antibodies 72 Drug Resistant 72 Benign Prostatic Hyperplasia 72 Improves Survival 72 Phase 2b Clinical Trial 72 Preclinical Models 72 Disease Progression 72 Severe Sepsis 72 Protease Inhibitors 72 Chronic Myeloid Leukemia 72 Vaccine Candidate 71 Atopic Dermatitis 71 Improves Outcomes 71 Pooled Analysis 71 Previously Treated 71 Fungal Infections 71 Kinase Inhibitors 71 Dendritic Cells 71 Novel Therapeutic 71 Treatment Naive Patients 71 Allergic Rhinitis 71 Treating Chronic 71 Advanced Colorectal Cancer 71 Kinase Inhibitor 71 Overactive Bladder 71 Patients Treated With 71 Combination Therapy 71 Investigational Treatment 71 Autoimmune Disease 71 Lupus Drug 71 Multiple Myeloma Patients 71 Advanced Melanoma 71 Infected Patients 71 Monoclonal Antibody 71 Insulin Resistance 71 Venous Thromboembolism 71 Phase III Trials 71 Bladder Cancer 70 Antitumor Activity 70 Immune Responses 70 Drug Candidate 70 Rheumatoid Arthritis Patients 70 Vaccine Adjuvant 70 Improve Survival 70 Drug Shows Promise 70 Nitazoxanide 70 Diabetic Neuropathy 70 Gene Mutation 70 Shows Promise Against 70 Meets Primary Endpoint 70 Survival Benefit 70 Osteoporosis Treatment 70 Rheumatoid Arthritis Drug 70 Stem Cell Treatment 70 Shows Efficacy 70 HCV Protease Inhibitor 70 Clinical Trial Results 70 Immune Mediated 70 Multidrug Resistant 70 Combo Therapy 70 Inflammatory Arthritis 70 Inflammatory Diseases 70 Viral Infections 70 RNAi Therapeutic 70 Tumor Targeting 70 Novel Mechanism 70 Mouse Model 70 Genital Herpes 70 Emerging Therapies 70 Malaria Vaccine 70 Renal Cancer 70 Proves Effective 70 Respiratory Syncytial Virus RSV 70 Protease Inhibitor 70 Inflammatory Disease 69 Treatment Reduces 69 Demonstrates Potent 69 Hepatitis B Vaccine 69 Inflammatory Markers 69 Antibacterials 69 Investigational Drug 69 Well Tolerated 69 Lung Cancer Drug 69 Breast Cancers 69 Antifungal 69 Prophylactic Treatment 69 Therapeutic Vaccine 69 Advanced Ovarian Cancer 69 Ischemic Stroke 69 Prostate Cancer Vaccine 69 Iron Overload 69 Immunotherapeutic 69 TB Vaccine 69 Genes Involved 69 Patients Receiving 69 Relapsed Refractory 69 Drug Combo 69 Initiates Phase III 69 Dengue Virus 69 Severe Asthma 69 Respiratory Virus 69 Slow Progression 69 Molecular Diagnostic 69 Antiviral Drugs 69 Breast Cancer Treatment 69 Newly Diagnosed Multiple Myeloma 69 Present Preclinical Data 69 JAK2 Inhibitor 69 Vaccine Protects Against 69 Treatment Shows Promise 69 Postmenopausal Women 69 Breast Tumors 69 Genes Linked 69 Maribavir 69 Therapeutic Potential 69 Antifungals 69 Novel Antibiotic 69 Pegylated Interferon 69 Cholesterol Lowering Drug 69 RNAi Therapeutics 69 Bone Metastases 69 Antiviral Activity 69 Shows Promising 69 Meta Analysis 69 Cancer Vaccines 69 Topical Treatment 69 Systematic Review 69 Oral Fingolimod 69 Malignancies 69 Hormone Refractory Prostate Cancer 69 Influenza Virus 69 Initiates Clinical Trial 69 Targeted Therapies 69 Improve Outcomes 69 Recombinant Human 69 Helicobacter Pylori 69 Adjuvant Chemotherapy 69 Smallpox Vaccine 69 Chronic Sinusitis 69 Phase III Clinical Trial 68 Appears Safe 68 Anthracycline 68 HER2 Positive Breast Cancer 68 Leukemias 68 Anti Tumor 68 Soft Tissue Sarcoma 68 Diabetic Patients 68 Antiangiogenic 68 Polymerase Inhibitor 68 Cancer Stem Cells 68 Cardiovascular Events 68 Clinical Outcome 68 Lowers Risk 68 Fabry Disease 68 Demonstrates Efficacy 68 Interferon Beta 68 Systemic Delivery 68 Investigational Compound 68 Asthma COPD 68 Fracture Risk 68 Initiate Clinical Trial 68 Avian Flu Vaccine 68 Anticoagulant 68 Complicated Skin 68 Advanced Prostate Cancer 68 Viral Suppression 68 Antipsychotic Medications 68 Postmenopausal Osteoporosis 68 Newly Diagnosed 68 Autoimmune Diseases 68 Treatment Experienced 68 Metastatic Prostate Cancer 68 Breast Cancer Recurrence 68 Brain Metastases 68 Investigational Agent 68 Unresectable 68 Prostate Cancer Patients 68 Novel Vaccine 68 Relapsing Multiple Sclerosis 68 Vitro Activity 68 Invasive Breast Cancer 68 Diabetic Foot Ulcer 68 Gene Linked 68 Urinary Incontinence 68 Phase IIb Clinical Trial 68 Cancer Therapies 68 JAK Inhibitor 68 Myocardial Ischemia 68 Preclinical Data 68 Anticancer Drug 68 Reduces Mortality 68 Diabetic Nephropathy 68 Recombinant Protein 68 Previously Untreated 68 Resistant Hypertension 68 Arthritis Drug 68 Retroviral 68 Stem Cell Transplant 68 Patients Suffering 68 Clostridium difficile Infection 68 Kidney Function 68 Therapeutic Effects 68 Chronic Constipation 68 Lung Cancer Patients 68 HER2 Positive 68 Influenza Vaccine 68 Neuroprotection 68 Metastatic Melanoma 68 Tuberculosis Vaccine 68 Juvenile Idiopathic Arthritis 68 Immune Cells 68 Treatment Naive HIV 68 Successfully Treated 68 Hepatitis C Infection 68 Genetic Testing 68 Anticancer Activity 68 Receives Orphan Drug Designation 68 Breast Cancer Metastasis 68 Tumor Growth 68 Chronic Lymphocytic Leukemia 68 Adjuvant Therapy 68 Tyrosine Kinase Inhibitor 68 Chronic Heart Failure 68 Vaccine Shows Promise 68 Lupus Nephritis 68 Efficacious 68 Phase IIb Trial 68 Molecular Diagnostic Test 68 Hypercholesterolemia 68 Seasonal Influenza Vaccine 68 Liver Injury 68 Thromboembolism 68 Treatment Regimen 68 Potent Antiviral Activity 68 Acute Heart Failure 67 Immune Cell 67 Successfully Completes Phase 67 Epilepsy Drug 67 Flu Virus 67 Bacterial Infections 67 Acute Ischemic Stroke 67 Osteoporosis Drug 67 Therapeutic Antibody 67 Pneumococcal Disease 67 Orally Active 67 Mouse Models 67 Neoplasia 67 Therapeutic Vaccines 67 Liver Failure 67 Phase 2b Study 67 Gout Drug 67 Hepatitis C Treatment 67 Acute Coronary Syndromes 67 Iron Deficiency 67 Improved Survival 67 Viral Load 67 Single Dose 67 Phase III Trial 67 Genetic Disorders 67 Anti Angiogenesis 67 Rheumatoid Arthritis RA 67 Uterine Fibroids 67 NMDA Receptor 67 Septic Shock 67 Treated Patients 67 Unfractionated Heparin 67 Hepatotoxicity 67 Novel Therapies 67 Small Molecule 67 Hospital Acquired Pneumonia 67 Presents Positive 67 Chronic Lymphocytic Leukemia CLL 67 Therapeutic Targets 67 Drug Resistant TB 67 Bacterial Infection 67 Protein Interactions 67 Cardiovascular Outcomes 67 Esophageal Cancer 67 Autoimmune Disorders 67 Metastatic Colorectal Cancer 67 Lung Cancer Survival 67 Predict Risk 67 Cervical Dysplasia 67 Genes Associated 67 Anemia Drug 67 Experimental Vaccine 67 Reduced Risk 67 Antiviral Drug 67 Adjuvant Treatment 67 Gum Disease 67 Genes Identified 67 Systemic Sclerosis 67 Initiates Clinical 67 Colorectal Adenomas 67 Test Detects 67 Drug Combinations 67 Statin Therapy 67 Potentially Fatal 67 Advanced Renal Cell 67 Valvular Heart Disease 67 Replacement Therapy 67 Tyrosine Kinase Inhibitors 67 Anti Tumor Activity 67 Oral Interferon 67 Immunotherapies 67 Epidermal Growth Factor Receptor 67 Oral Mucositis 67 Immune Therapy 67 Endometrial Cancer 67 Patients Treated 67 Sustained Efficacy 67 Genetic Variation 67 Antisense Drug 67 Effective Treatments 67 Therapy Shows Promise 67 Beneficial Effects 67 Effectively Treats 67 Novel Oral 67 Potent Inhibitor 67 Study Evaluating 67 Completes Patient Enrollment 67 Novel Small Molecule 67 Phase 2a Trial 67 Metabolic Disorder 67 Cardiotoxicity 67 Retrovirus 67 Naive Patients 67 Randomized Clinical Trials 67 Prospective Randomized 67 HIV Infection 67 Cutaneous T 67 Develop Novel 67 Neoplasms 66 Brain Tumors 66 Hepatitis C Genotype 66 Metabolic Disease 66 Genes Predict 66 Elderly Patients 66 Respiratory Syncytial Virus 66 Pneumococcal Vaccine 66 Neural Stem Cells 66 Kidney Failure 66 Myeloma Patients 66 Begin Clinical Trials 66 Significantly Improved 66 Genotypes 66 Drug Prevents 66 Hsp# Inhibitor 66 Eye Diseases 66 Pediatric Patients 66 Immunomodulatory 66 Increased Risk 66 Companion Diagnostic 66 Nonalcoholic Steatohepatitis 66 Long Term Efficacy 66 Serious Infections 66 Schizophrenia Drug 66 Data Suggest 66 Shown Effective 66 FDA Approvals 66 Gastrointestinal Disorders 66 Breast Cancer Patients 66 Nanoemulsion 66 Cethromycin 66 Preclinical Study 66 Signaling Pathway 66 MRSA Infections 66 Gastrointestinal Stromal Tumors 66 Telbivudine 66 Efficacy Trial 66 Malignant Glioma 66 Hepatic Encephalopathy 66 Prevent Stroke 66 Antiretroviral Therapy 66 Antibiotic Resistant 66 Is Well Tolerated 66 See CLINICAL PHARMACOLOGY 66 Chemotherapeutic Agents 66 Nucleoside 66 Colorectal Cancer Patients 66 Disease Causing 66 Preterm Delivery 66 Insulin Glargine 66 Drug Fails 66 Tigecycline 66 Dose Escalation 66 Lipodystrophy 66 Thyroid Cancer 66 Blood Clots 66 Synthetic Peptide 66 Hemodialysis Patients 66 Acute Renal Failure 66 Treatment Resistant 66 Statistically Significant 66 Allergic Asthma 66 Hormone Receptor Positive 66 Inhibits 66 Estrogen Receptor 66 Vicriviroc 66 Diagnostic Tests 66 Cholesterol Drug 66 Pafuramidine 66 Antibody Discovery 66 Diarrheal 66 Combination Therapies 66 Demonstrates Positive 66 Hypertensive Patients 66 Nicotine Vaccine 66 Minimally Invasive Treatment 66 Oral Insulin 66 Proven Effective 66 Initiates Enrollment 66 Nymox NX 66 Stomach Cancer 66 Detect Cancer 66 Prostate Cancer Treatment 66 Stakeholder Opinions 66 Immunosuppressive 66 Randomized Controlled Trial 66 C1 Inhibitor 66 Angiogenic 66 Pathogenesis 66 Solid Tumors 66 Lung Cancer Trial 66 Lung Injury 66 Initiates Dosing 66 Transdermal Delivery 66 Castration Resistant Prostate Cancer 66 Cytomegalovirus 66 Osteoporosis Drugs 66 Lymphoid 66 Aggressive Prostate Cancer 66 Therapy Improves 66 Genetic Tests 66 Protein Linked 66 Thrombotic 66 Thyroid Hormone 66 Psoriasis Patients 66 Atypical Hemolytic Uremic Syndrome 66 Lanthanum Carbonate 66 Multicenter Trial 66 Analytical Tool 66 Aliskiren 66 Cancer Immunotherapy 66 FDA Okays 66 Obesity Linked 66 Commonly Used 66 Chronic Prostatitis 66 Bloodstream Infections 66 Stem Cell Transplants 66 Hormone Therapy 66 Ovarian Cancer Patients 66 Protein Involved 66 Breast Tumor 66 Therapeutic Efficacy 66 Adefovir 66 Ischemic 66 Sapacitabine 66 Bosutinib 66 Interferon Alpha 66 HCV Infection 66 Demonstrates Significant 66 Rotavirus Vaccines 66 Adjuvanted 66 Fondaparinux 66 Pandemic Flu Vaccine 66 ACE Inhibitors 66 Fewer Side Effects 66 Preclinical Efficacy 66 Respiratory Infections 66 Phase III Clinical Trials 66 Secondary Hyperparathyroidism 66 Early Diagnosis 66 Drug Resistant Bacteria 66 Randomized Study 66 Adenomas 66 Breast Cancer Cells 66 Presents Preclinical Data 66 Demonstrates Sustained 66 Placebo Controlled Trial 66 Monotherapy 65 Predict Breast Cancer 65 Genetic Disorder 65 Phase 2b Trial 65 Immunogenicity 65 Ventricular Arrhythmias 65 Subgroup Analysis 65 H. Pylori 65 Blood Thinner 65 Maven Semantic 65 SARS Virus 65 Omacetaxine 65 Dose Finding 65 Circulating Tumor Cells 65 Regimens 65 Valopicitabine 65 First Patient Dosed 65 Novel Anticancer 65 Renal Anemia 65 Migraine Headaches 65 Viral Infection 65 Confirms Efficacy 65 Contrast Agents 65 Initiate Phase 65 Vaccine Trial 65 Premature Infants 65 Subtypes 65 Chronic HCV 65 Chronic Inflammation 65 Antitumor 65 Localized Prostate Cancer 65 Transdermal Patch 65 Refractory Hodgkin Lymphoma 65 Guidelines Issued 65 Critically Ill Patients 65 Disease Modifying 65 Peginterferon 65 Psoriasis Drug 65 Files IND 65 Chronic Renal Failure 65 Neoadjuvant Chemotherapy 65 Virus Infections 65 Rheumatoid Arthritis 65 Nilotinib 65 Demonstrated Significant 65 Study Showed 65 Cervical Cancer Vaccine 65 Carotid Stenting 65 Neurodegenerative 65 Respiratory Distress 65 Antibiotic Resistance 65 Clinically Significant 65 Protein Therapeutics 65 Immunologic 65 Chemoradiation 65 Universal Flu Vaccine 65 Adenoviral 65 Pegylated 65 Liver Cancer 65 Novel Treatments 65 Doctors Warn 65 Patient Enrollment 65 Cancer Vaccine 65 Associated Diarrhea 65 Rheumatoid 65 Cognitive Problems 65 Patients Undergoing 65 Brain Scans 65 Immunomedics Announces 65 IND Application 65 Immunostimulatory 65 Genital Warts 65 Genetic Markers 65 Bazedoxifene 65 Atypical Antipsychotics 65 Male Infertility 65 Glatiramer Acetate 65 Hepatitis C Patients 65 Diagnosis Treatment 65 Bipolar Mania 65 Invasive Fungal Infections 65 Treatment Naïve 65 Cancer Treatments 65 Prognostic Significance 65 Decitabine 65 Low Dose 65 Psychiatric Disorders 65 Microbicide 65 Entry Inhibitor 65 Antiplatelet Therapy 65 Enlarged Prostate 65 Increases Risk 65 Inhaled Corticosteroids 65 Aurora Kinase 65 Combination Vaccine 65 Prophylaxis 65 Neuropathic Pain 65 Skeletal Muscle 65 Tumor Suppressor 65 Radical Prostatectomy 65 Kidney Transplants 65 Bird Flu Vaccine 65 Advanced Pancreatic Cancer 65 Relapsing Remitting Multiple Sclerosis 65 Long Term Survival 65 Cholesterol Drugs 65 Phase IIa Clinical Trial 65 Differential Diagnosis 65 Targeted Therapy 65 Hepatitis C Virus HCV 65 Generalized Anxiety Disorder 65 Cognitive Impairment 65 Blood Pressure Drug 65 Pivotal Phase III 65 Adenoma 65 Immunosuppressant 65 Osteoarthritis Patients 65 Non Alcoholic Fatty 65 Versus Placebo 65 Vaccine Trials 65 Nonalcoholic Fatty Liver Disease 65 Postmenopausal 65 Obese Patients 65 Gene Mutations 65 Shingles Vaccine 65 Cytotoxic 65 Oligonucleotides 65 Genetic Marker 65 Neutralizing Antibodies 65 Estrogen Therapy 65 Prenatal Diagnosis 65 Urinary Tract Infections 65 Observational Study 65 CYT# potent vascular disrupting 65 Bacterial Vaginosis 65 Genetic Mutation 65 Erythropoietic 65 Community Acquired Pneumonia 65 Tumor Cell 65 Prostate Cancers 65 Slows Progression 65 Skin Cancers 65 Blood Transfusions 65 Hematological Malignancies 65 Cellular Immunotherapy 65 Randomized Phase 65 Postherpetic Neuralgia 65 Premenopausal Women 65 Bone Marrow Transplants 64 Recurrent Breast Cancer 64 Stress Urinary Incontinence 64 Insulin Sensitivity 64 Randomized Double Blind 64 Vaccine Prevents 64 Hedgehog Pathway Inhibitor 64 Growth Hormone Deficiency 64 Knee Osteoarthritis 64 Prostate Biopsy 64 Dyslipidemia 64 Help Detect 64 Unstable Angina 64 Fixed Dose 64 Safinamide 64 Antiviral Therapy 64 Phase 2a Clinical Trial 64 Clinical Trial Data 64 Controlled Trial 64 Anticancer Agent 64 Daclizumab 64 Cognitive Deficits 64 Laryngeal Cancer 64 Bacteremia 64 Suicidality 64 Rectal Cancer 64 Muscle Wasting 64 Enzyme Replacement Therapy 64 Virus Linked 64 Metastatic Cancer 64 Cytomegalovirus CMV 64 Study Indicates 64 Insulin Delivery 64 BARACLUDE R 64 Antiviral 64 Fixed Dose Combination 64 Gene Variant 64 Pharmacokinetics PK 64 Vaginal Gel 64 Metabolic Disorders 64 Prolongs Life 64 Artery Disease 64 abacavir Ziagen 64 Oncolytic 64 Completes Enrollment 64 Somatostatin 64 Nasal Powder 64 Alemtuzumab 64 Helps Predict 64 Myelodysplastic Syndrome MDS 64 Uric Acid 64 Data Indicate 64 simplex virus 64 Meningococcal Disease 64 Double Blind Placebo 64 Cell Lymphoma 64 RNA Interference 64 Adjunctive 64 Pivotal Trials 64 Clinical Efficacy 64 Pharmacokinetic Study 64 Treatment Naive 64 MMR Vaccine 64 Tiotropium 64 Tipranavir 64 Pivotal Phase 64 Mesenchymal Stem Cells 64 Help Diagnose 64 Kidney Transplant Patients 64 cytomegalovirus infection 64 Colorectal Screening 64 Trial Evaluating 64 Cancer Cells 64 DNA Methylation 64 Atypical Antipsychotic 64 Inhaled Liposomal Ciprofloxacin 64 Sleep Disturbances 64 Combination REOLYSIN R 64 Antiretrovirals 64 Ebola Vaccine 64 Menopausal Women 64 Randomized Controlled Trials 64 Renal Function 64 Autologous Stem Cell Transplantation 64 Lymphocytic 64 Receives Positive Opinion 64 Anticancer Drugs 64 Cocaine Addiction 64 Proliferative 64 Follicular Lymphoma 64 Initiates Phase II 64 Comorbidities 64 Patent Covering 64 Companion Diagnostics 64 Milestone Payment 64 Taxane 64 Pre Exposure Prophylaxis 64 Stakeholder Insight 64 Protein Synthesis 64 Small Intestine 64 Left Ventricular Dysfunction 64 STELARA TM 64 Leukemia Cells 64 Chronic Myelogenous Leukemia 64 Gene Variation 64 Herpes Simplex Virus 64 Gender Differences 64 Sustained Release 64 Bone Fractures 64 FDA Approves Drug 64 Therapeutic Agents 64 Allergic Reactions 64 Chemoprevention 64 Predict Response 64 Autoimmune 64 Prognostic Factors 64 Hospitalized Patients 64 Antithrombotic 64 Hemorrhagic Stroke 64 Stent Thrombosis 64 Treating Depression 64 Gram Negative 64 Hepatitis C HCV 64 Reduce Mortality 64 Idiopathic Pulmonary Fibrosis 64 Adjunctive Therapy 64 Diabetic Retinopathy 64 Poorly Controlled 64 Relapsed Multiple Myeloma 64 Meet Primary Endpoint 64 Help Predict 64 Dual Antiplatelet Therapy 64 Ozarelix 64 Antibiotic Use 64 Myelofibrosis 64 Pandemic Influenza Vaccine 64 Acute Pancreatitis 64 Tesamorelin 64 Cytotoxicity 64 Diastolic Heart Failure 64 Allogeneic 64 Catheter Associated 64 Renal Impairment 64 Teva Provides Update 64 Anti Inflammatory Drug 64 Genetic Variations 64 Carcinoid Syndrome 64 Factor Receptor 64 Periodontal Disease 64 Gene Variants 64 ST Elevation Myocardial 64 Renal Artery 64 Endovascular Treatment 64 II Clinical Trial 64 MEK Inhibitor 64 Conjugate 64 Survival Rates 64 Antidepressant Drug 64 Parathyroid Hormone 64 Pleural Mesothelioma 64 HIV Integrase 64 Cardiometabolic 64 Papillomavirus 64 Therapeutic Antibodies 64 Pregnancy Linked 64 Organ Rejection 64 Coronary Arteries 64 Phase III Pivotal 64 Depressive Symptoms 64 Carcinomas 64 Patient Outcomes 64 Pneumonia Vaccine 64 Malignant Pleural Mesothelioma 64 Chronic Cough 64 Premature Aging 64 TNF Blockers 64 Tumor Response 64 Childhood Asthma 64 Oxidative Stress 64 Randomized Phase II 64 Golimumab 64 Squamous 64 Treatment Naïve Patients 64 Flu Strain 64 Prostate Tumors 64 Effective Than 64 Amniotic Fluid 64 Demonstrates Potential 64 Significantly Reduced 64 NICE Recommends 63 Asymptomatic 63 Meningitis Vaccine 63 Epstein Barr Virus EBV 63 Cardiac Function 63 Blood Cancers 63 Fluorouracil 63 Cognitive Decline 63 Diabetic Kidney Disease 63 Potent Anti 63 Presents Preclinical 63 Radiofrequency Ablation 63 Sipuleucel T 63 Macrolide 63 Onychomycosis 63 Tamiflu Resistant 63 Advanced Solid Tumors 63 Bucindolol 63 Pivotal Study 63 Submits NDA 63 Total Knee Arthroplasty 63 Intracerebral 63 Aptamer 63 Rabies Vaccine 63 Migraine Treatment 63 Metastases 63 Cell Transplants 63 HDAC Inhibitor 63 Antiplatelet 63 Cold Sores 63 Tumor Angiogenesis 63 Mimetics 63 Related Viruses 63 Acne Drug 63 Eye Infections 63 Metastatic Disease 63 Diabetic Macular Edema 63 Neuroendocrine Tumors 63 Antigens 63 Lung Function 63 Clinical Trials Review 63 Rapidly Increasing 63 Significantly Improves 63 Albuferon TM 63 Randomized Trials 63 Skin Lesions 63 Gram Positive 63 Clinical Trial Evaluating 63 Reduces Risk 63 Liver Metastases 63 Etiology 63 HeFH 63 Develops Novel 63 Genetic Predisposition 63 Antiretroviral Drug 63 Receives Milestone Payment 63 Renal Tumors 63 Oritavancin 63 Antibody Drug Conjugate 63 Chronic Pelvic Pain 63 Preterm Birth 63 Metastatic Renal Cell Carcinoma 63 Asthma Symptoms 63 Anti TNF 63 Integrase Inhibitor 63 Streptococcus Pneumoniae 63 Smooth Muscle 63 Epilepsy Drugs 63 Bipolar Depression 63 Cannabinoid 63 Cognitive Function 63 Statin Drugs 63 Dasatinib 63 Biomarker Panel 63 Often Misdiagnosed 63 Drug Regimen 63 Angioedema 63 Personalised Medicine 63 Holds Promise 63 Thromboembolic 63 Pertuzumab 63 Study Evaluates 63 Malaria Parasite 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 Asthma Attacks 63 Peanut Allergy 63 Colorectal Cancer Screening 63 Commonly Prescribed 63 Acute Promyelocytic Leukemia 63 Cardiovascular Disease Risk 63 Potentially Deadly 63 Antibiotic Treatment 63 ORENCIA ® 63 Completes Dosing 63 FDA Clears 63 Acute Migraine 63 Novel Therapeutics 63 Ovarian Cancers 63 Molecular Basis 63 Demonstrates Statistically Significant 63 Symptom Relief 63 Ovarian Cancer Treatment 63 Transplant Patients 63 Peginterferon Alfa 2a 63 Oral Cladribine 63 Monoclonal antibody 63 Pre Eclampsia 63 Injectable Drug 63 Kidney Transplantation 63 Toxicogenomics 63 Peripheral Blood 63 Radiation Induced 63 Being Studied 63 Polymorphism 63 Human Papillomavirus 63 Antiretroviral 63 Tumor Cells 63 Diabetic Foot Ulcers 63 Liver Toxicity 63 Malignancy 63 Chemotherapy Induced 63 Colon Polyps 63 Multicenter Randomized 63 Menopausal Symptoms 63 Breast Ultrasound 63 Aflibercept 63 Avian Flu Virus 63 Neuroprotective Effects 63 Generic Versions 63 Initiate Phase III 63 Adjuvant 63 Increased Mortality 63 Prove Effective 63 Dapagliflozin 63 Genetic Variant 63 Protease 63 Hematological Cancers 63 Tocilizumab 63 Biomarker 63 Genetic Susceptibility 63 Irritable Bowel 63 Modulates 63 Antidepressant Use 63 Could Prevent 63 Achieves Primary Endpoint 63 Kidney Transplant Recipients 63 Higher Doses 63 Ear Infections 63 Nosocomial 63 Cell Proliferation 63 Blood Pressure Lowering 63 Neurodegenerative Disease 63 Hematological 63 Human Monoclonal Antibodies 63 Tezampanel 63 Randomized Controlled 63 Tumor Necrosis Factor 63 invasive candidiasis 63 Showed Significant 63 Watchful Waiting 63 Immunosuppression 63 Oral Anticoagulants 63 Liver Cirrhosis 63 Cerebrospinal Fluid 63 Human Monoclonal Antibody 63 Faropenem 63 adalimumab Humira 63 Placebo Controlled Study